The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Other > Centaur Pharmaceuticals, Inc.

Centaur Pharmaceuticals, Inc.
 PROFILE
Centaur Pharmaceuticals is developing nitrone-related therapeutics (NRTs) to treat strokes and such illnesses as Parkinson's disease, AIDS dementia, and Alzheimer's disease. These conditions involve stress agents, such as the cell-damaging oxygen agents called free radicals, which Centaur hopes to neutralize with its oral and intravenous drug candidates. Centaur Pharmaceuticals is also investigating the use of its NRT technology to treat arthritis, inflammatory bowel disease, heart attacks, and other conditions. The firm has a research and marketing pact with AstraZeneca for its stroke and Alzheimer's treatments.

 COMPETITION
Amgen Inc. (AMGN)
Cortex Pharmaceuticals, Inc. (COR)
NeoTherapeutics, Inc. (NEOT)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 7.10
1-Yr. Sales Growth: (26.0)%
Employees: 73
Revenue per employee: $97,260.27

 KEY PEOPLE
• Paul L. Wood
    CEO
• Lucy O. Day
    CFO

 CONTACT INFO
1220 Memorex Dr.
Santa Clara, CA 95050
US
Phone: 408-822-1600
Fax: 408-822-1601
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001